Schizoaffective Disorder

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2006-07-19
Clinical Trial Update: The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder [Phase 4]
Phase 4 trial completed evaluating a weight-gain agent for treating olanzapine-associated weight gain in patients with schizophrenia, schizo…